Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solithromycin in NASH
NCT02510599Phase 2Completed
- Sponsor
- Melinta Therapeutics
- Start
- Dec 2015
- Primary completion
- Jan 2017
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of solithromycin in Nonalcoholic steatohepatitis (NASH), sponsored by Melinta Therapeutics. Started Dec 2015; status: completed.
02
Drugs
solithromycin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02510599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02510599.